Michael Wilkinson • UCSD Profiles (original) (raw)

  1. Therapeutic Plasma Exchange and Evinacumab for Homozygous Familial Hypercholesterolemia. JACC Case Rep. 2026 Feb 11; 31(6):106407. Raygani S, Sykes AV, Sanchez AP, Witztum JL, Wilkinson MJ. PMID: 41369603; PMCID: PMC12905687.
    View in: PubMed Mentions:
  2. Lipoprotein(a) testing trends in young ischemic stroke patients from 2015-2024: An analysis of 188,000 individuals. J Stroke Cerebrovasc Dis. 2026 Jan; 35(1):108513. Naguib M, Meyer BC, Felipe F, Cuomo RE, Wilkinson M, Mahmud E, Taub P, Bhatia HS, Ramsis M. PMID: 41338528.
    View in: PubMed Mentions: Fields:
    Translation:Humans
  3. Impact of PCSK9 Inhibitors on Lipoprotein(a) Levels: A Multi-Center Study. Eur J Prev Cardiol. 2025 Nov 18. Bhatia HS, Cuomo R, Ramsis M, Mahmud E, Taub P, Wilkinson MJ. PMID: 41253688.
    View in: PubMed Mentions: Fields:
  4. Short-term 24h dietary recalls from observational studies cannot support claims on mortality. Diabetes Metab Syndr. 2025 Oct; 19(10):103316. Manoogian ENC, Peterson CM, Sears DD, Playdon M, Banks S, Bonham M, Chaix A, Chow LS, Coletta A, De Cabo R, Desplats P, Dibner C, Gabel K, Johnson SL, Kriegsfeld LJ, Hardikar S, Hawley JA, Heilbronn LK, Hogenesch J, James DL, Kleckner AS, Laferrère B, Marinac C, Panda S, Parr E, Pendergast JS, Quist JS, Ravussin E, Scheer FAJL, Swiatkiewicz I, Takahashi JS, Taub PR, Termannsen AD, Varady KA, Wilkinson MJ, Zee PC, Collet TH. PMID: 41218440.
    View in: PubMed Mentions: Fields:
  5. Impact of Triglycerides and Remnant Particles on Hemodynamic Valve Deterioration After Transcatheter Aortic Valve Replacement. JACC Adv. 2025 Nov; 4(11 Pt 1):102247. Sampath-Kumar R, Padilla E, Wilkinson M, Torres Barba D, Aramburo N, Mahmud E, Ben-Yehuda O, Taub P. PMID: 41124988; PMCID: PMC12589977.
    View in: PubMed Mentions:
  6. Lipoprotein(a) Testing Trends in the United States 2015-2024: An Analysis of 300 Million Individuals. JACC Adv. 2025 Nov; 4(11 Pt 1):102205. Ramsis M, Naguib M, Dzotsi M, Wilkinson M, Mahmud E, Taub P, Bhatia HS. PMID: 40992240; PMCID: PMC12495319.
    View in: PubMed Mentions:
  7. Global lipoprotein (a) testing trends from 2015 to 2023. Am Heart J. 2025 Nov; 289:171-179. Hanif M, Khan LA, Kulkarni A, Bhatia HS, Wilkinson MJ, Rashid AM, Chew NWS, Banerjee S, Butler J, Shapiro MD, Khan MS. PMID: 40550301.
    View in: PubMed Mentions: Fields:
    Translation:Humans
  8. Insights from a real-world experience with inclisiran at a large United States lipid clinic. J Clin Lipidol. 2025 Jul-Aug; 19(4):812-818. Mazdeyasnan D, Birs A, Chiou T, Diano L, Wilkinson MJ. PMID: 40670197.
    View in: PubMed Mentions: Fields:
    Translation:Humans
  9. Multidisciplinary teams in clinical lipidology and cardiometabolic care: A National Lipid Association Expert Clinical Review. J Clin Lipidol. 2025 Jul-Aug; 19(4):737-747. Cheeley MK, Kirkpatrick CF, Brown EE, Dixon DL, Gunter H, Osborn DS, Wilkinson MJ. PMID: 40483195.
    View in: PubMed Mentions: Fields:
    Translation:Humans
  10. Real-World Effectiveness and Safety of Evinacumab in Children and Adults With Homozygous Familial Hypercholesterolemia: A Multisite US Perspective-Brief Report. Arterioscler Thromb Vasc Biol. 2025 Jul; 45(7):1310-1315. Wilkinson MJ, Bijlani P, Davidson MH, Duell PB, Horan M, Malloy MJ, Newfield RS, Pradeep P, Shah PK, Stock EO, Warden BA, Ito MK. PMID: 40438928.
    View in: PubMed Mentions: 3 Fields:
    Translation:Humans
  11. Lorundrostat Efficacy and Safety in Patients with Uncontrolled Hypertension. N Engl J Med. 2025 May 08; 392(18):1813-1823. Laffin LJ, Kopjar B, Melgaard C, Wolski K, Ibbitson J, Bhikam S, Weir MR, Ofili EO, Mehra R, Luther JM, Cohen DL, Sarraju A, Wilkinson MJ, Flack JM, Rodman D, Nissen SE, Advance-HTN Investigators. PMID: 40267417.
    View in: PubMed Mentions: 24 Fields:
    Translation:HumansCTClinical Trials
  12. JCL Roundtable: Dietary recommendations and intermittent fasting and time-restricted eating. J Clin Lipidol. 2025 Jul-Aug; 19(4):748-758. Maki KC, Kirkpatrick CF, Wilkinson MJ, Petersen KS. PMID: 40118712.
    View in: PubMed Mentions: 1 Fields:
    Translation:Humans
  13. Burden of atherogenic lipids and association with cardiac allograft vasculopathy in heart transplant recipients. J Clin Lipidol. 2025 Jan-Feb; 19(1):134-145. Birs AS, Kao AS, Silver E, Adler ED, Taub PR, Wilkinson MJ. PMID: 39542809.
    View in: PubMed Mentions: 2 Fields:
    Translation:Humans
  14. Immune-Mediated Inflammatory Diseases, Dyslipidemia, and Cardiovascular Risk: A Complex Interplay. Arterioscler Thromb Vasc Biol. 2024 Dec; 44(12):2396-2406. Wilkinson MJ, Shapiro MD. PMID: 39479765; PMCID: PMC11602385.
    View in: PubMed Mentions: 16 Fields:
    Translation:HumansAnimals
  15. Time-Restricted Eating in Adults With Metabolic Syndrome : A Randomized Controlled Trial. Ann Intern Med. 2024 Nov; 177(11):1462-1470. Manoogian ENC, Wilkinson MJ, O'Neal M, Laing K, Nguyen J, Van D, Rosander A, Pazargadi A, Gutierrez NR, Fleischer JG, Golshan S, Panda S, Taub PR. PMID: 39348690; PMCID: PMC11929607.
    View in: PubMed Mentions: 22 Fields:
    Translation:Humans
  16. Unique features of dyslipidemia in women across a lifetime and a tailored approach to management. Am J Prev Cardiol. 2024 Jun; 18:100666. Patel N, Mittal N, Wilkinson MJ, Taub PR. PMID: 38634109; PMCID: PMC11021917.
    View in: PubMed Mentions: 13
  17. A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice. J Clin Lipidol. 2024 May-Jun; 18(3):e308-e319. Koschinsky ML, Bajaj A, Boffa MB, Dixon DL, Ferdinand KC, Gidding SS, Gill EA, Jacobson TA, Michos ED, Safarova MS, Soffer DE, Taub PR, Wilkinson MJ, Wilson DP, Ballantyne CM. PMID: 38565461.
    View in: PubMed Mentions: 85 Fields:
  18. Harnessing RNA Interference for Cholesterol Lowering: The Bench-to-Bedside Story of Inclisiran. J Am Heart Assoc. 2024 Mar 19; 13(6):e032031. Wilkinson MJ, Bajaj A, Brousseau ME, Taub PR. PMID: 38456415; PMCID: PMC11010004.
    View in: PubMed Mentions: 15 Fields:
    Translation:Humans
  19. Time-Restricted Eating: A Novel Dietary Strategy for Cardiac Rehabilitation. Can J Cardiol. 2023 11; 39(11S):S384-S394. Small S, Iglesies-Grau J, Gariepy C, Wilkinson M, Taub P, Kirkham A. PMID: 37734709.
    View in: PubMed Mentions: 6 Fields:
    Translation:Humans
  20. Is Lipoprotein(a) Clinically Actionable with Today's Evidence? The Answer is Yes. Curr Cardiol Rep. 2023 10; 25(10):1175-1187. Ma GS, Chiou TT, Wilkinson MJ. PMID: 37632608; PMCID: PMC10651710.
    View in: PubMed Mentions: 3 Fields:
    Translation:Humans
  21. Evolving Management of Low-Density Lipoprotein Cholesterol: A Personalized Approach to Preventing Atherosclerotic Cardiovascular Disease Across the Risk Continuum. J Am Heart Assoc. 2023 06 06; 12(11):e028892. Wilkinson MJ, Lepor NE, Michos ED. PMID: 37260036; PMCID: PMC10381990.
    View in: PubMed Mentions: 25 Fields:
    Translation:Humans
  22. Trends in LDL-C following coronary angiography involving assessment by fractional flow reserve in obstructive vs non-obstructive coronary artery disease. Am J Prev Cardiol. 2023 Mar; 13:100473. Wilkinson MJ, Xu I, Vasudevan RS, You H, Xu R, Taub PR. PMID: 36865903; PMCID: PMC9971059.
    View in: PubMed Mentions: 3
  23. Inclisiran creates unique opportunities and challenges for patient access to therapy: early experience in a United States Lipid Clinic. J Clin Lipidol. 2023 Jan-Feb; 17(1):73-77. Chiou TT, Tomasi K, Taub PR, Wilkinson MJ. PMID: 36371372.
    View in: PubMed Mentions: 8 Fields:
    Translation:Humans
  24. Risk of advanced fibrosis in first-degree relatives of patients with nonalcoholic fatty liver disease. J Clin Invest. 2022 11 01; 132(21). Tamaki N, Ahlholm N, Luukkonen PK, Porthan K, Sharpton SR, Ajmera V, Kono Y, Dave S, Ahmed A, Sundaram V, Wilkinson MJ, Patton H, Gupta H, Cervantes V, Hernandez C, Lopez SJ, Loomba R, Baumgartner A, Richards L, Arkkila PE, Nemes K, Isoniemi H, Yki-Järvinen H, Loomba R. PMID: 36317632; PMCID: PMC9621132.
    View in: PubMed Mentions: 22 Fields:
    Translation:Humans
  25. Lipoprotein(a): Evidence for Role as a Causal Risk Factor in Cardiovascular Disease and Emerging Therapies. J Clin Med. 2022 Oct 13; 11(20). Bhatia HS, Wilkinson MJ. PMID: 36294361; PMCID: PMC9604626.
    View in: PubMed Mentions: 22
  26. Trends in testing and prevalence of elevated Lp(a) among patients with aortic valve stenosis. Atherosclerosis. 2022 05; 349:144-150. Bhatia HS, Ma GS, Taleb A, Wilkinson M, Kahn AM, Cotter B, Yeang C, DeMaria AN, Patel MP, Mahmud E, Reeves RR, Tsimikas S. PMID: 35144769; PMCID: PMC9674369.
    View in: PubMed Mentions: 11 Fields:
    Translation:Humans
  27. Heart Failure and Diabetes Mellitus: Defining the Problem and Exploring the Interrelationship. Am J Cardiol. 2019 12 15; 124 Suppl 1:S3-S11. Wilkinson MJ, Zadourian A, Taub PR. PMID: 31741438.
    View in: PubMed Mentions: 19 Fields:
    Translation:Humans
  28. Ten-Hour Time-Restricted Eating Reduces Weight, Blood Pressure, and Atherogenic Lipids in Patients with Metabolic Syndrome. Cell Metab. 2020 01 07; 31(1):92-104.e5. Wilkinson MJ, Manoogian ENC, Zadourian A, Lo H, Fakhouri S, Shoghi A, Wang X, Fleischer JG, Navlakha S, Panda S, Taub PR. PMID: 31813824; PMCID: PMC6953486.
    View in: PubMed Mentions: 439 Fields:
    Translation:HumansCTClinical Trials
  29. Lipoprotein(a) in Patients Undergoing Transcatheter Aortic Valve Replacement. Angiology. 2019 Apr; 70(4):332-336. Ma GS, Wilkinson MJ, Reeves RR, Yeang C, DeMaria AN, Cotter B, Patel M, Mahmud E, Tsimikas S. PMID: 30700108.
    View in: PubMed Mentions: 9 Fields:
    Translation:HumansCells
  30. Inappropriate ICD Shock From Perceived Ventricular Fibrillation During Balloon Manipulation at the Time of Percutaneous Coronary Intervention. J Invasive Cardiol. 2017 Aug; 29(8):E94-E95. Pourdjabbar A, Wilkinson MJ, Ang L, Reeves RR, Mahmud E, Patel MP. PMID: 28756425.
    View in: PubMed Mentions: 3 Fields:
    Translation:Humans
  31. The Prevalence of Lipoprotein(a) Measurement and Degree of Elevation Among 2710 Patients With Calcific Aortic Valve Stenosis in an Academic Echocardiography Laboratory Setting. Angiology. 2017 Oct; 68(9):795-798. Wilkinson MJ, Ma GS, Yeang C, Ang L, Strachan M, DeMaria AN, Tsimikas S, Cotter B. PMID: 28068801.
    View in: PubMed Mentions: 11 Fields:
    Translation:Humans
  32. Texts for Talking: Evaluation of a Mobile Health Program Addressing Speech and Language Delay. Clin Pediatr (Phila). 2016 Oct; 55(11):1044-9. Olson KB, Wilkinson CL, Wilkinson MJ, Harris J, Whittle A. PMID: 27554765.
    View in: PubMed Mentions: 9 Fields:
    Translation:Humans
  33. Lipoprotein(a) and oxidized phospholipids in calcific aortic valve stenosis. Curr Opin Cardiol. 2016 07; 31(4):440-50. Yeang C, Wilkinson MJ, Tsimikas S. PMID: 27205885; PMCID: PMC4956483.
    View in: PubMed Mentions: 37 Fields:
    Translation:Humans
  34. Overcoming toxicity and side-effects of lipid-lowering therapies. Best Pract Res Clin Endocrinol Metab. 2014 Jun; 28(3):439-52. Wilkinson MJ, Laffin LJ, Davidson MH. PMID: 24840269.
    View in: PubMed Mentions: 20 Fields:
    Translation:Humans
  35. Use of microsomal triglyceride transfer protein inhibitors in patients with homozygous familial hypercholesterolemia: translating clinical trial experience into clinical practice. Rev Cardiovasc Med. 2014; 15(1):1-10. Toth PP, Shah PK, Wilkinson MJ, Davidson MH, McCullough PA. PMID: 24762461.
    View in: PubMed Mentions: 2 Fields:
    Translation:Humans
  36. Recent developments in the treatment of familial hypercholesterolemia: a review of several new drug classes. Curr Treat Options Cardiovasc Med. 2013 Dec; 15(6):696-705. Wilkinson MJ, Davidson MH. PMID: 24222265.
    View in: PubMed Mentions:
  37. Age-related variation in red blood cell stable isotope ratios (delta13C and delta15N) from two Yupik villages in southwest Alaska: a pilot study. Int J Circumpolar Health. 2007 Feb; 66(1):31-41. Wilkinson MJ, Yai Y, O'Brien DM. PMID: 17451132.
    View in: PubMed Mentions: 16 Fields:
    Translation:HumansCells

This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.

This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.

Start with: newest oldestInclude: line numbers double spacing all authors publication IDs